Adma Biologics (ADMA) Debt Ratio (2012 - 2025)

Adma Biologics has reported Debt Ratio for 13 years, with the latest figure at 0.12 in Q4 2025.

• For the quarter ending Q4 2025, Debt Ratio fell 21.93% year-over-year to 0.12; the trailing twelve-month figure through Dec 2025 stood at 0.12 (down 21.93% YoY), and the FY2025 full-year result was 0.12, down 21.93% from the prior year.
• Debt Ratio for Q4 2025 stood at 0.12, down from 0.13 in the prior quarter.
• The five-year high for Debt Ratio was 0.47 in Q2 2022, with the low at 0.12 in Q4 2025.
• Historically, Debt Ratio has averaged 0.33 across 5 years, with a median of 0.4 in 2021.
• Annual changes were most pronounced in 2021 — Debt Ratio jumped 459.41% — and 2024, when it sank 62.69%.
• Adma Biologics' Debt Ratio stood at 0.34 in 2021, then gained by 19.36% to 0.41 in 2022, then retreated by 3.21% to 0.4 in 2023, then slumped by 62.69% to 0.15 in 2024, then decreased by 21.93% to 0.12 in 2025.
• The last three Debt Ratio figures came in at 0.12 (Q4 2025), 0.13 (Q3 2025), and 0.13 (Q2 2025), per Business Quant data.